NCT04651530Recruiting
Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma
Source: ClinicalTrials.gov · Last updated 22 Dec 2020 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to assess whether endoscopic cyclophotocoagulation added to cataract surgery lowers intraocular pressure more than cataract surgery alone in patients with normal tension glaucoma.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 26 Nov 2020
- Start date
- 8 Dec 2020
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Helsinki University Central Hospital
- Diseases
- Glaucoma
- NCT number
- NCT04651530
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 8 Dec 2020 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Secondary Glaucoma e.g. due to previous injury or uveitis
- Previous transscleral or endoscopic cyclophotocoagulation
- Previous other glaucoma surgery
- Previous retinal detachment
- Previous intraocular surgery like vitrectomy and other retinal surgery
- Previous corneal transplant or previous refractive surgery
Other illness
- Exfoliation syndrome
- Pigment dispersion syndrome
- Zonular weakness due to Marfan syndrome or other
- Dementia
Age
- Wet age-related macular degeneration
Other
- Cataract due to eye injury or congenital cataract
- Diabetic retonopathy
- Fuchs' dystrophy and other abnormalities compromising corneal clarity like scars
- The patient does not want to participate in the study
- The glaucoma progresses on current IOP
- The patient does not speak Finnish, Swedish or English
- Only eye with vision worse than 20/200 or loss of central visual field
Who the study is looking for
- Signed Informed Consent
- Normal Tension Glaucoma with typical nerve fiber layer defects in red-free photographs and/or optical coherence tomography (OCT) and possible equivalent visual field defects, IOP never more than 21 mmHg, and open anterior chamber angle
- Glaucoma stable with current medication assessed by a glaucoma specialist
- Clinically significant cataract
Age in the registry: 55 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Helsinki University Hospital Coordinator of this site? Confirm its status | Helsinki | Finland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.